Close Menu

Pharma's Problems

In an analysis column in the British Medical Journal, York University's Joel Lexchin and Donald Light from the University of Medicine and Dentistry of New Jersey say that the "widely touted 'innovation crisis' in pharmaceuticals is a myth," and that the real problem in pharma is that current incentives reward companies for making drugs that are only marginally better than existing products.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

A WHO panel is calling for a global registry of human germline gene-editing projects, according to Stat News.

Matt Hancock, the UK health secretary, is calling for the swift rollout of predictive genetic tests, the Guardian reports.

Vox writes that lab mishaps involving pathogens are quite common.

In Genome Biology this week: analysis of wild and cultivated peach genomes, Hi-C-based pipeline for assembling microbial genomes from metagenomic data, and more.